Chemical Compound
N-[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic acid (3S)-tetrahydro-3-furanyl ester; Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3S)-tetrahydro-3-furanyl ester (9CI); Carbamic acid, [3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, tetrahydro-3-furanyl ester, [3S-[3R*(1R*,2S*)]]-; 141W94; APV; Agenerase; Amprenavir; Angenerase; KVX 478; Prozei; Samprenavir; VX 478; VX-478; 141W94; GW 433908G Fosamprenavir Calcium Test Mix 1; GW 773543; GW 569683; GW 638469; GW 638468; GW 569686; GW 783579; GW 833074; Amprenavir; GW 634519; GW 587304; GW 461013X; 4949W94 (GW 288003X); GW 395126X; 3489W95; GW 422708X; GW 475728X; GW 327664X; GW 327662X; GW 327663X
CAS Registry Number
161814-49-9
Primary record
N-[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic acid (3S)-tetrahydro-3-furanyl ester; Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3S)-tetrahydro-3-furanyl ester (9CI); Carbamic acid, [3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, tetrahydro-3-furanyl ester, [3S-[3R*(1R*,2S*)]]-; 141W94; APV; Agenerase; Amprenavir; Angenerase; KVX 478; Prozei; Samprenavir; VX 478; VX-478; 141W94; GW 433908G Fosamprenavir Calcium Test Mix 1; GW 773543; GW 569683; GW 638469; GW 638468; GW 569686; GW 783579; GW 833074; Amprenavir; GW 634519; GW 587304; GW 461013X; 4949W94 (GW 288003X); GW 395126X; 3489W95; GW 422708X; GW 475728X; GW 327664X; GW 327662X; GW 327663X
- 库存
- 9,213 克
- 纯度
- 98.6 %
- CAS
- 161814-49-9
化合物标识与属性
- CAS
- 161814-49-9
- PubChem CID
- 65016
- SMILES
- CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N
- Canonical SMILES
- CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1
名称与同义词
- amprenavir
- Agenerase
- Prozei
- 161814-49-9
- Vertex
- angenerase
- Vertex VX478
- samprenavir
- Amprenavir [USAN]
- amprenavir[usan]
- Amprenavirum
- VX-478
- Amprenavir (agenerase)
- Agenerase (TM)
- Agenerase (TN)
- GNA & Amprenavir
- HHA & Amprenavir
- 1hpv
- 3ekp
- 3ekv
- 3nuj
- 3nuo
- KVX-478
- 141W94
- VX 478
- 1t7j
- 3nu3
- 3nu4
- 3nu5
- 3nu6
- 3nu9
- 3sm2
- AMPRENAVIR [MI]
- RefChem:54192
- C25H35N3O6S
- AMPRENAVIR [INN]
- AMPRENAVIR [JAN]
- 5S0W860XNR
- AMPRENAVIR [HSDB]
- GlyTouCan:G27511PE
- UNII-5S0W860XNR
- AMPRENAVIR [VANDF]
- APV & AAG
- APV & HSA
- CHEBI:40050
- CHEMBL116
- D0A0OO
- Amprenavir (JAN/USAN/INN)
- Amprenavir [USAN:INN:BAN]
- DRG-0258
- HSDB 7157
- AC1L22EW
- AC1Q5X5K
- AMPRENAVIR [MART.]
- J05AE05
- AMPRENAVIR [WHO-DD]
- VX478
- MFCD00934214
- SCHEMBL34151
- DTXSID5046061
- MLS006011492
- AMPRENAVIR [EMA EPAR]
- BIDD:GT0398
- ALPHA-LACTOSEMONOHYDRATE
- YMARZQAQMVYCKC-OEMFJLHTSA-N
- orb1300812
- AMPRENAVIR [ORANGE BOOK]
- Amprenavir, 98% - 5mg 5mg
- Amprenavir & human serum albumin
- EX-A6824B
- GTPL12681
- KVX 478
- 3s43
- 3s45
- DTXCID601765661
- GLXC-06443
- HMS2090N10
- CID65016
- G27511PE
- KS-00000L2H
- ZINC3809192
- AN-502
- BDBM50215393
- C25-H35-N3-O6-S
- CID:65016
- EBC-13715
- s1639
- Amprenavir & alpha1-acid glycoprotein
- AKOS000280844
- AM84544
- BCP9000297
- CB10251
- CCG-269742
- CS-1410
- CS-O-11599
- DB00701
- FA17892
- MP-1964
- NCGC00159461-02
- NCGC00159461-07
- NCGC00159461-08
- AJ-45667
- Amprenavir 100 microg/mL in Acetonitrile
- AS-30915
- HY-17430
- SC-14018
- SID:53790789
- SMR003885056
- 141w94, kvx-478, agenerase, prozei,
- BCP0726000051
- AB0008692
- AB2000184
- LS-173559
- ST2419097
- 141 W94
- A8201
- NS00004082
- SW219687-1
- (3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate
- J1.015.291G
- A11985
- C08086
- D00894
- EN300-123443
- SBI-0653847.0001
- Tetrahydro-3-furyl N-(3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxypropyl)carbamate
- (3S-(3R*(1R*,2S*)))-(3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl) tetrahydro-3-furanyl carbamate
- 24228-EP2272516A2
- 24228-EP2298761A1
- 24228-EP2298783A1
- 24228-EP2314590A1
- AB01275534-01
- AB01275534_02
- APV
- 141W-94
- 814A499
- A810295
- C095108
- Q422198
- SR-05000001530
- (S)-tetrahydrofuran-3-yl ((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate
- [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate
- AMV
- Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3S)-tetrahydro-3-furanyl ester
- SR-05000001530-1
- BRD-K47827687-001-02-2
- (3S)-oxolan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)(4-aminobenzene)sulfonamido]-1-phenylbutan-2-yl]carbamate
- {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER
- Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester
- Z1551900491
- (3S)-Tetrahydro-3-furyl ((alphaS)-alpha-((1R-1-hydroxy-2-(N(sup 1)-isobutylsulfanilamido)ethyl)phenethyl)carbamate
- [(3S)-tetrahydrofuran-3-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate
- AMP
- (3S)-oxolan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate
- (3S)-tetrahydro-3-furyl N-[(1S,2R)-3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxy-propyl]carbamate
- 4-Amino-N-((2 syn,3S)-2-hydroxy-4-phenyl-3-((S)-tetrahydrofuran-3-yloxycarbonylamino)-butyl)-N-isobutyl-benzenesulfonamide
- Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Galanthus nivalis agglutinin (GNA)
- Carbamic acid, (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, tetrahydro-3-furanyl ester, (3S-(3R*(1S*,2R*)))-
- ((3S)-oxolan-3-yl) N-((2S,3R)-4-((4-aminophenyl)sulfonyl-(2-methylpropyl)amino)-3-hydroxy-1-phenylbutan-2-yl)carbamate
- (3S)-Oxolan-3-yl {(2S,3R)-4-[4-amino-N-(2-methylpropyl)benzene-1-sulfonamido]-3-hydroxy-1-phenylbutan-2-yl}carbamate
- (3S)-oxolan-3-yl N-((2S,3R)-3-hydroxy-4-(N-(2-methylpropyl)(4-aminobenzene)sulfonamido)-1-phenylbutan-2-yl)carbamate
- (3S)-oxolan-3-yl N-((2S,3R)-3-hydroxy-4-(N-(2-methylpropyl)4-aminobenzenesulfonamido)-1-phenylbutan-2-yl)carbamate
- (3S)-oxolan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)-4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate
- (3S)-Tetrahydro-3-furyl [(alphaS)-alpha-[(1R-1-hydroxy-2-(N1-isobutylsulfanilamido)ethyl]phenethyl]carbamate
- (3S)-tetrahydrofuran-3-yl [(1S,2R)-3-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-benzyl-2-hydroxypropyl]carbamate
- (3S)-tetrahydrofuran-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate
- (S)-tetrahydrofuran-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate
- [(1S,2R)-1-Benzyl-2-hydroxy-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]propyl]carbamic acid (S)-tetrahydrofuran-3-yl ester
- [(2S,3R)-3-Hydroxy-4-[isobutyl(4-aminophenylsulfonyl)amino]-1-phenylbutane-2-yl]carbamic acid (3S)-oxolane-3-yl ester
- 4-Amino-N-isobutyl-N-[(2R,3S)-2-hydroxy-4-phenyl-3-[[(3S)-3-oxolanyl]oxycarbonylamino]butyl]benzenesulfonamide
- 827-179-5
- Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Hippeastrum hybrid agglutinin( HHA)
- Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Hippeastrum hybrid agglutinin(HHA)
- Carbamic acid, (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(-phenylmethyl)propyl)-, tetrahydro-3-furanyl ester, (3S-(3R*(1S*,2R*)))-
- Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3S)-tetrahydro-3-furanyl ester
- Carbamic acid,[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-,(3S)-tetrahydro-3-furanyl ester
- N-[(1S,2R)-1-Benzyl-2-hydroxy-3-[2-methylpropyl[(4-aminophenyl)sulfonyl]amino]propyl]carbamic acid (3S)-tetrahydrofuran-3-yl ester
- N-[(1S,2R)-3-[(2-Methylpropyl)[(4-aminophenyl)sulfonyl]amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic acid tetrahydrofuran-3beta-yl ester
- N-[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic acid (3S)-tetrahydro-3-furanyl ester; Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3S)-tetrahydro-3-furanyl ester (9CI); Carbamic acid, [3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, tetrahydro-3-furanyl ester, [3S-[3R*(1R*,2S*)]]-; 141W94; APV; Agenerase; Amprenavir; Angenerase; KVX 478; Prozei; Samprenavir; VX 478; VX-478; 141W94; GW 433908G Fosamprenavir Calcium Test Mix 1; GW 773543; GW 569683; GW 638469; GW 638468; GW 569686; GW 783579; GW 833074; Amprenavir; GW 634519; GW 587304; GW 461013X; 4949W94 (GW 288003X); GW 395126X; 3489W95; GW 422708X; GW 475728X; GW 327664X; GW 327662X; GW 327663X
- N-[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic acid (3S)-tetrahydro-3-furan yl ester
- N-[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid (3S)-Tetrahydro-3-furanyl Ester
- N-[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic acid (3S)-tetrahydro-3-furanyl ester, VX-478